Presentation of superantigen by human T cell clones: a model of T-T cell interaction.
Superantigens (SAg) interact with T lymphocytes bearing particular V beta sequences as part of their T cell receptor (TcR). The interaction, however, requires the presence of major histocompatibility complex (MHC) class II molecules on antigen-presenting cell (APC). In peculiar circumstances, MHC class II+ T cell clones (TCC) have been shown to present peptides and selected antigens interacting with antigen-specific TCC in the absence of APC. In this report we studied the capacity of SAg to mediate a T-T cell interaction, investigating the TCC ability to present a panel of staphylococcal enteroxins (SE) independently of the presence of added APC. Upon exposure to a broad range of SE concentrations, MHC class II+ TCC showed an intense proliferative response even in the absence of professional APC. Diverse SE optimally stimulated responder TCC at different concentrations. The proliferation was inhibited by anti-DR monoclonal antibodies, both in the presence and in the absence of APC. The SE activation of TCC in the absence of APC induced the same series of phenotypic variations as that observed following the TCC stimulation with APC. Irradiated TCC efficiently presented membrane-bound SE to responder TCC as well as professional APC. These results show that a single cell of a given clone effectively presents the SE to other cells of the same clone, and provide evidence that SAg can efficiently mediate T-T cell interaction. In addition, the possibility also exists that one cell of the clone can actually undergo an auto-stimulation via SAg-mediated interactions between its own TcR and MHC class II molecule. It has recently been suggested that the V beta-selective depletion of T cells observed in acquired immunodeficiency syndrome (AIDS) patients might be a consequence of the interaction between a human immunodeficiency virus (HIV)-encoded SAg and T cells expressing a SAg complementary V beta. We suggest that the hypothesized HIV-encoded SAg might mediate T-T cell interactions that could play a relevant role in the V beta-selective depletion of T lymphocytes observed in HIV-infected patients.
D.A.S.R.S. Rep. Medicina, Lab. Immunologia, Pomezia Roma, Italy.
R
R
Nisini
P M
PM
Matricardi
A
A
Fattorossi
R
R
Biselli
R
R
D'Amelio
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology; D000938:Antigen-Presenting Cells / Q000502:physiology*; D000942:Antigens, Bacterial / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000502:physiology; D002450:Cell Communication; D002999:Clone Cells; D004768:Enterotoxins / Q000276:immunology*; D015488:HIV Antigens / Q000276:immunology; D006801:Humans; D008213:Lymphocyte Activation; D010641:Phenotype; D013211:Staphylococcus aureus / Q000276:immunology*; D013601:T-Lymphocytes / Q000502:physiology*
D000942:Antigens, Bacterial; D004768:Enterotoxins; D015488:HIV Antigens